FDA Inspection 1068602 — Rare Disease Therapeutics, Inc.
The FDA completed an inspection of Rare Disease Therapeutics, Inc. on Sep 28, 2018 in Franklin, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 28, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Franklin, TN (United States)